Hosur, India

Wesley R Balasubramanian

This inventor holds 1 USPTO granted patent. Top assignee: Aurigene Discovery Technologies Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wesley R Balasubramanian. Retrieved from https://idiyas.com/inventor/wesley-r-balasubramanian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wesley R Balasubramanian: Innovator in Hematological Treatments

Introduction

Wesley R Balasubramanian is a notable inventor based in Hosur, India. He has made significant contributions to the field of medicine, particularly in the treatment of hematological disorders. His innovative work focuses on developing compounds that can effectively combat serious health conditions.

Latest Patents

Wesley holds a patent for "Compounds and compositions for treating hematological disorders." This invention provides methods for treating conditions such as acute myeloid leukemia. The patented compounds are designed to inhibit IRAK4 and FLT-3 kinases, offering a promising approach to managing these disorders. He has 1 patent to his name.

Career Highlights

Wesley is currently associated with Aurigene Discovery Technologies Limited, where he continues to work on groundbreaking research. His role in the company allows him to collaborate with other experts in the field and contribute to the advancement of medical science.

Collaborations

Some of his notable coworkers include Venkateshwar Rao Gummadi and Susanta Samajdar. Their collective expertise enhances the innovative environment at Aurigene Discovery Technologies Limited.

Conclusion

Wesley R Balasubramanian is a dedicated inventor whose work in hematological treatments showcases the potential of innovative compounds in medicine. His contributions are paving the way for new therapeutic options for patients suffering from serious blood disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…